Abstract
Form IV of the calcium channel blocker, Felodipine was obtained consistently via solvent evaporation in a pH-controlled solution, and followed by large-scale crystallization through seeding the saturated solution of Felodipine. Comparing with form I, the crystal form used in the marketed products, form IV has higher melting temperature but lower melting enthalpy. Hence, according to the heat of fusion rule, polymorphs I and IV should be in an enantiotropic relationship. Form I is thermodynamically more stable than form IV at room temperature. Their theoretical polymorphic transformation temperature was estimated at 87.6 °C, which was also confirmed by the solvent-mediated polymorphic transformation experiments.
References
Desiraju GR. Polymorphism: the same and not quite the same. Cryst Growth Des. 2008;8:3–5.
Láng P, Kiss V, Ambrus R, Farkas G, Szabó-Révész P, Aigner Z, Várkonyi E. Polymorph screening of an active material. J Pharm Biomed Anal. 2013;84:177–83.
Elguero J. Polymorphism and desmotropy in heterocyclic crystal structures. Cryst Growth Des. 2011;11:4731–8.
Haleblian J, McCrone W. Pharmaceutical applications of polymorphism. J Pharm Sci. 1969;58:911–29.
Aaltonen J, Allesø M, Mirza S, Koradia V, Gordon KC, Rantanen J. Solid form screening–a review. Eur J Pharm Biopharm. 2009;71:23–37.
Perlovich GL, Blokhina SV, Manin NG, Volkova TV, Tkachev VV. Polymorphs and solvates of felodipine: analysis of crystal structures and thermodynamic aspects of sublimation and solubility processes. CrystEngComm. 2012;14:8577–88.
Lu J, Rohani S. Polymorphism and crystallization of active pharmaceutical ingredients (APIs). Curr Med Chem. 2009;16:884–905.
Cabri W, Ghetti P, Pozzi G, Alpegiani M. Polymorphisms and patent, market, and legal battles: cefdinir case study. Org Process Res Dev. 2007;11:64–72.
Nussinovitch N, Carroll J, Shamiss A, Grossman E, Katz A, Rachima C, Rosenthal T. Felodipine in the treatment of severe refractory hypertension. J Hum Hypertens. 1996;10:S165–7.
Srčič S, Kerč J, Urleb U, Zupančič I, Lahajnar G, Kofler B, Šmid-Korbar J. Investigation of Felodipine polymorphism and its glassy state. Int J Pharm. 1992;87:1–10.
Lou B, Boström D, Velaga SP. Polymorph control of Felodipine form II in an attempted cocrystallization. Cryst Growth Des. 2009;9:1254–7.
Surov AO, Solanko KA, Bond AD, Perlovich GL, Bauer-Brandl A. Crystallization and polymorphism of Felodipine. Cryst Growth Des. 2012;12:4022–30.
Crystal data for Felodipine form IV: C18H19Cl2NO4, formula weight = 384.24, monoclinic, space group P 21/n, a = 11.2433 (7) Å, b = 12.6209 (9) Å, c = 13.5826 (9) Å, β (deg) = 107.774(7), V = 1835.4 (2) Å3, Z = 4, Mo Kα radiation, λ = 0.71073 Å, T = 223 (2) K, 7551 reflections collected, 3421 unique. Final GooF = 1.041, R1 = 0.0988, wR2 = 0.2681. The crystal data are in line with previous report (CCDC: 864027).
Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 2006;95:2692–705.
Song YJ, Wang LY, Yang P, Wenslow Jr RM, Tan B, Zhang HL, Deng ZW. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion. J Pharm Sci. 2013;102:1915–23.
Fossheim R. Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data. J Med Chem. 1986;29:305–7.
Chadha R, Arora P, Garg M, Bhandari S, Jain DS. Thermoanalytical and spectroscopic studies on different crystal forms of nevirapine. J Therm Anal Calorim. 2013;111:2133–42.
Terada K, Kurobe H, Ito M, Yoshihashi Y, Yonemochi E, Fujii K, Uekusa H. Polymorphic and pseudomorphic transformation behavior of acyclovir based on thermodynamics and crystallography. J Therm Anal Calorim. 2013;113:1261–7.
Chickos JS, Acree WE. Enthalpies of vaporization of organic and organometallic compounds, 1880–2002. J Phys Chem Ref Data. 2003;32:519–878.
Burger A, Ramberger R. On the polymorphism of pharmaceuticals and other molecular crystals. I. Mikrochim Acta. 1979;72:259–71.
Bauer-Brandl A, Marti E, Geoffroy A, Poso A, Suurkuusk J, Wappler E, Bauer KH. Comparison of experimental methods and theoretical calculations on crystal energies of ‘isoenergetic’ polymorphs of Cimetidine. J Therm Anal Calorim. 1999;57:7–22.
Acknowledgements
This work was supported by the Natural Science Foundation of China (No. 21205129) and Jiangsu Provincial Fund for Natural Sciences (No. BK2012191).
Author information
Authors and Affiliations
Corresponding authors
Supporting Information
10973_2014_4083_MOESM1_ESM.doc
13C solid state NMR spectra and TGA curves of Felodipine form I&IV, comparison of the experimental and theoretical powder XRD patterns of Form IV after Rietveld refinement, and DSC curve of Felodipine form I at a heating rate of 1.0 °C min−1. (DOC 1261 kb)
Rights and permissions
About this article
Cite this article
Wang, L., Song, Y., Yang, P. et al. Preparation and thermodynamic properties of Felodipine form IV. J Therm Anal Calorim 120, 947–951 (2015). https://doi.org/10.1007/s10973-014-4083-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-014-4083-x